Transfusion Management for ccEE K‑ Rh⁺ Phenotype

Antigen‑Matching Recommendations

For patients who may require transfusion, matching donor red cells for C, c, E, e, and K antigens is strongly recommended to prevent alloimmunization. 1
The American Society of Hematology advises prophylactic red‑cell antigen matching for Rh antigens (C, E or C/c, E/e) and K antigens in individuals receiving chronic transfusions, because antibodies to these antigens are among the most common and clinically significant. 1
Individuals with the ccEE K‑ Rh⁺ phenotype should receive donor units that are c‑positive, C‑negative, E‑positive, and e‑negative to avoid formation of anti‑c, anti‑C, anti‑E, or anti‑e antibodies. 1

Antibodies directed against C, E, and K antigens are historically the most frequent specificities that complicate transfusion therapy. 1
Extended matching for Rh and K antigens reduces the incidence of newly formed alloantibodies from approximately 3.1 per 100 transfused units (with only ABO/RhD matching) to 0.9 per 100 units when comprehensive antigen matching is employed. 1

Standard ABO/RhD matching alone is insufficient for patients requiring ongoing transfusions; extended phenotype matching markedly lowers the risk of transfusion‑related complications. 1
Should alloantibodies develop, each additional antibody further limits the availability of compatible donor blood, making subsequent transfusion increasingly challenging. 1

In pregnant individuals with the ccEE K‑ Rh⁺ phenotype, the antigen profile may be relevant for the risk of hemolytic disease of the fetus and newborn if maternal–fetal Rh incompatibility occurs. 1

Although the ccEE K‑ Rh⁺ phenotype is less common than some other Rh patterns, it is not rare; the principal clinical implication is the need for precise antigen matching during transfusion to prevent alloimmunization and its associated adverse outcomes. 1